Healthcare in 2022 Will Be Complex
Healthcare is complex. We like simple. So we try to make healthcare simple, which has worked for now, but not ...
Vaccine Mandates Strike at the Heart of Patient Autonomy
Much has been said about the resistance to vaccine mandates. But beneath the rhetoric is the core issue - the ...
The App is Now Your Doctor
Healthcare innovators assume patients trust healthcare technology. But trust in technology wanes when patients lose autonomy. So instead of trust, ...
Harm Reduction Means Patient Education
The government can right many wrongs by focusing on harm reduction policies to combat the rising number of deaths by ...
Abortion is a Right, but Roe is Wrong
Abortion is defined as a right to privacy in Roe v. Wade. The ruling protects a fundamental right but it ...
The Omicron Narrative
The new variant is upon us and the narrative has been set, repeating many of the familiar reactions we have ...
Where to Receive COVID-19 Treatment
As much as we discuss the drugs used to treat COVID-19, few know where to receive them should they develop ...
Is Europe a Leading Indicator for COVID-19?
As we enter the second pandemic winter, we look for signs indicating whether COVID-19 will worsen. Europe has typically served ...
Exceptions to Common Sense Law
The courts recently ruled vaccine mandates as unconstitutional and against public interests. But by emphasizing economic interests over public health ...
Of Thoughts and Language
The push for healthcare equity has profoundly changed the way we view healthcare, including how we speak in medical settings. ...
Financial Toxicity
Mr. S did everything he could to beat his cancer. In the end, it was not the cancer but the ...
The Hospital’s Eyes
Paul the hospital janitor may appear lowly in the eyes of those who pass him by. However, he keenly observes ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more